Carisbamate clinical trials

Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

This study is testing a new medicine, carisbamate, for people aged 4-55 with Lennox-Gastaut Syndrome (LGS). It aims to see if carisbamate helps reduce certain seizures, like 'drop seizures', and if it's safe to use.